AGP Limited announced earnings results for the first half 2018. For the period, the company reported profit after tax (PAT) of PKR 676 million (EPS: PKR 2.42), reflecting a growth of 12% year on year. Growth in earnings during the period was mainly on account of 22% year on year growth in sales revenue where the company benefited from a bulk government institutional order for its Hepatitis C products, along with healthy growth in its overall portfolio.

The company provided tax rate guidance for the year 2018. The management also pointed out that effective tax rate during 2018 will average around 16-17% due to tax credits accruing from IPO.